TechSci Healthcare Industry Report

Increasing incidence of immunological diseases is expected to drive the growth of India immunology drugs market during the forecast period. According to TechSci Research report,  “ India  Immunology Drugs Market  By Drug Class (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication, Others), By Indication (Arthritis, Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant Rejection, Others), By Application (Hospitals, Clinics, Cancer Research Institute, Others), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India immunology drugs market is expected to grow at a formidable rate during the forecast period on account of surging drug research and development. Rising prevalence of chronic ailments such as spondylitis, inflammatory bowel disease, arthritis in the country is bolstering the demand for immunological drugs and medications. In addition to this, growing adoption of imm...

  Increasing incidence of immunological diseases is expected to drive the growth of India immunology drugs market during the forecast period. According to TechSci Research report,  “ India  Immunology Drugs Market  By Drug Class (Monoclonal Antibodies (mAb), Antibody Drug Conjugates, Interferon and Cytokine therapies, Immunosuppressive medication, Others), By Indication (Arthritis, Plaque Psoriasis, Spondylitis, Inflammatory Bowel Disease, Transplant Rejection, Others), By Application (Hospitals, Clinics, Cancer Research Institute, Others), By Company, By Region, Forecast & Opportunities, FY2026 ” , the India immunology drugs market is expected to grow at a formidable rate during the forecast period on account of surging drug research and development. Rising prevalence of chronic ailments such as spondylitis, inflammatory bowel disease, arthritis in the country is bolstering the demand for immunological drugs and medications. In addition to this, growing adoption...